Gillian Dohrn
Gillian Dohrn is GeekWire’s first Etzioni Intern in Climate Tech Journalism, supported by a grant from Oren and Eli Etzioni. She recently completed a master’s program in science communication at the University of California, Santa Cruz.
By Gillian
See all 4Talus Bioscience Raises $11.2M to Develop Drugs Targeting Undruggable Gene-Regulating Proteins
Seattle biotech Talus Bioscience raised $11.2 million in venture capital to advance its drug discovery platform targeting undruggable gene-regulating proteins linked to diseases. Founded in 2020 by Alex Federation and Lindsay Pino, Talus uses its MARMOT platform and machine learning to study transcription factors within living cells.
Sana Biotechnology Opens $80M Manufacturing Facility in Bothell to Scale Cancer and Gene Therapy Production
Sana Biotechnology inaugurated its new 80,000 square-foot manufacturing facility in Bothell, Washington, dedicated to producing its proprietary cancer drug program and future therapies. The company, known for its gene-editing technology and multiple drugs in human trials including for cancer, autoimmune diseases, and type 1 diabetes, sees this expansion as a key step in advancing scalable cell and gene therapies.
Bill Gates' Breakthrough Energy Ventures Raises $839 Million New Fund for Climate Innovation
Bill Gates' Breakthrough Energy Ventures is raising a new $839 million fund focused on climate innovations across electricity, transportation, manufacturing, buildings, and agriculture. Since its 2015 launch with industry leaders like Jeff Bezos and Mark Zuckerberg, the initiative has invested nearly $2 billion in over 100 companies.
Organizations
-
GeekWire Etzioni Intern in Climate Tech Journalism · current
